Glenmark Pharmaceuticals (BOM:532296) Accounts Payable : ₹25,359 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Accounts Payable?

Glenmark Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2024 was ₹25,359 Mil.

Glenmark Pharmaceuticals's quarterly Accounts Payable declined from Sep. 2023 (₹19,173 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹25,359 Mil).

Glenmark Pharmaceuticals's annual Accounts Payable increased from Mar. 2022 (₹22,887 Mil) to Mar. 2023 (₹23,919 Mil) and increased from Mar. 2023 (₹23,919 Mil) to Mar. 2024 (₹25,359 Mil).

Glenmark Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Glenmark Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Accounts Payable Chart

Glenmark Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable

Get a 7-Day Free Trial

21,258.43

22,377.68

22,886.62

23,918.61

25,359.25

Glenmark Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															23,918.61	-	19,172.73	-	25,359.25

Glenmark Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Glenmark Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Glenmark Pharmaceuticals (BOM:532296) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (BOM:532296) » Definitions » Accounts Payable

Traded in Other Exchanges

GLENMARK:India

Address

Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099

Website

https://www.glenmarkpharma.com

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (BOM:532296) Headlines

No Headlines